Jump to main content
Jump to site search


Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives as antiglioma agents

Author affiliations

Abstract

D-2-Hydroxyglutarate (D-2HG) is frequently found in human brain cancers. Approximately 50–80% of grade II glioma patients have a high level of D-2HG production, which can lead to cancer initiation. In this study, a series of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives were designed and synthesized as antiglioma agents, and their related structure–activity relationships are discussed. Among these novel compounds, 4a exhibited promising anti-proliferative activity against glioma HT1080 cells and U87 cells with an IC50 of 1.43 μM and 4.6 μM, respectively. Further studies found that the most active compound (4a) shows an 86.3% inhibitory rate against the intracellular production of D-2HG at 1 μM, and dramatic inhibitory effects, even at 1 μM on the colony formation and migration of U87 and HT1080 cells.

Graphical abstract: Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives as antiglioma agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 31 Oct 2017, accepted on 16 Jan 2018 and first published on 19 Jan 2018


Article type: Research Article
DOI: 10.1039/C7MD00551B
Citation: Med. Chem. Commun., 2018, Advance Article
  •   Request permissions

    Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives as antiglioma agents

    Y. Li, W. Hou, H. Lin, P. Sun, J. Lin and W. Chen, Med. Chem. Commun., 2018, Advance Article , DOI: 10.1039/C7MD00551B

Search articles by author

Spotlight

Advertisements